These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 2933950

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Short- and long-term effects of calcium entry blockers on the kidney.
    Bauer JH, Reams G.
    Am J Cardiol; 1987 Jan 23; 59(2):66A-71A. PubMed ID: 3544786
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C, Golub MS, Eggena P, Barrett JD, Sambhi MP.
    J Cardiovasc Pharmacol; 1984 Jan 23; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [Abstract] [Full Text] [Related]

  • 7. The renal response to diltiazem and nifedipine: comparison with nitroprusside.
    Blackshear JL, Orlandi C, Williams GH, Hollenberg NK.
    J Cardiovasc Pharmacol; 1986 Jan 23; 8(1):37-43. PubMed ID: 2419690
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nitrendipine, a calcium-entry blocker. Renal and humoral effects in human arterial hypertension.
    Pedrinelli R, Fouad FM, Tarazi RC, Bravo EL, Textor SC.
    Arch Intern Med; 1986 Jan 23; 146(1):62-5. PubMed ID: 2935106
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
    Katzman PL, Henningsen NC, Fagher B, Thulin T, Hulthén UL.
    J Cardiovasc Pharmacol; 1990 Mar 23; 15(3):360-4. PubMed ID: 1691357
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The influence of diltiazem and nifedipine on renal function in the rat.
    Johns EJ.
    Br J Pharmacol; 1985 Mar 23; 84(3):707-13. PubMed ID: 3986432
    [Abstract] [Full Text] [Related]

  • 16. Nitrendipine reverses vasoconstriction and renal hemodynamic changes in experimental hypertension.
    Sterzel RB, Huelsemann JL, McKenzie DE, Wilcox CS.
    J Cardiovasc Pharmacol; 1984 Mar 23; 6 Suppl 7():S1024-7. PubMed ID: 6085360
    [Abstract] [Full Text] [Related]

  • 17. Renal hemodynamic and tubular transport effects of nitrendipine.
    Wallia R, Greenberg A, Puschett JB.
    J Lab Clin Med; 1985 Apr 23; 105(4):498-503. PubMed ID: 3156937
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of atrial natriuretic peptide in the diuretic effect of Ca2+ entry blockers.
    Shamiss A, Peleg E, Rosenthal T, Ezra D.
    Eur J Pharmacol; 1993 Mar 16; 233(1):113-7. PubMed ID: 8472740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.